Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR, NMPA) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

Clinical Trial

Remote ECG Monitoring Post TAVI

NCT: NCT07521800 · RECRUITING

NCT IDNCT07521800
StatusRECRUITING
Start Date2023-12-01
Completion2028-02-01

Brief Summary

The DRAGON TAVI study is a multicenter, prospective, open, randomised trial, which will enrol 250 patients, randomized 1:1 to the study group (continuous 30-day ECG monitoring with visits triggered by ECG findings) and standard care (ie. control group, which will receive the standard post op 24-48h ECG monitoring and a regular follow-up visit with standard ECG within 30 days). The duration of the study is 12 months ± 1 month.

Frequently Asked Questions

What is Remote ECG Monitoring Post TAVI?

Remote ECG Monitoring Post TAVI is a clinical trial registered under NCT07521800. Current status: RECRUITING.

What is the status of NCT07521800?

The current status of NCT07521800 (Remote ECG Monitoring Post TAVI) is: RECRUITING.

When did Remote ECG Monitoring Post TAVI start?

Remote ECG Monitoring Post TAVI started on 2023-12-01.

Official Source

View on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov API. For the most current status, refer to the official record.